Lanean...
Engineering virus-like particles as vaccine platforms
Virus-like particles (VLPs) have been utilized as vaccine platforms to increase the immunogenicity of heterologous antigens. A variety of diverse VLP types can serve as vaccine platforms, and research has focused on engineering VLPs to improve their efficacy as vaccines, enhance their stability, and...
Gorde:
| Argitaratua izan da: | Curr Opin Virol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983494/ https://ncbi.nlm.nih.gov/pubmed/27039982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2016.03.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|